Schubert & Co’s Tenet Healthcare THC Stock Holding History

Schubert & Co’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7	Closed	-$416	–	1368
2023 Q1	$416	Buy	+7	New	+$389	﹤0.01%	1455
2022 Q4	–	Sell	-2	Closed	–	–	1651
2022 Q3	$0	Sell	2 -1	-33%	-$59	﹤0.01%	1580
2022 Q2	$0	Sell	3 -2	-40%	-$139	﹤0.01%	1593
2022 Q1	$0	Buy	5 +2	+67%	+$164	﹤0.01%	1333
2021 Q4	$0	Buy	+3	New	+$219	﹤0.01%	1285

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schubert & Co's THC Position: Q2 2023 in Review

Schubert & Co sold out of Tenet Healthcare (THC) in Q2 2023, closing a stake of 7 shares — an estimated $416 sold.

Schubert & Co first reported a position in THC in Q4 2021 and held it in 5 quarters. The position peaked at $416 in Q1 2023. 416 funds tracked by Wall St. Rank hold THC as of Q2 2023.

Schubert & Co reported no remaining Tenet Healthcare position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 7 Tenet Healthcare shares in Q2 2023, an estimated $416.
Schubert & Co first reported a position in Tenet Healthcare in Q4 2021 and held it in 5 quarters.
Schubert & Co's Tenet Healthcare position peaked at $416 in Q1 2023.
416 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.